Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
514 13, 514 14, 514 15, 530324, 530326, 530327, 530328, 530350, 530357, 4352402, 43524021, 43524023, 43524024, 43524025, A61K 3810, A61K 3818
Synthetic peptides corresponding to different regions of the human keratin 1 chain can disassemble preformed keratin intermediate filaments or inhibit filament assembly both in vitro and in vivo. The disruption of keratin filaments may have therapeutic applications in the treatment of epithelial abnormalities.
Steinert et al., J. Biol. Chem., vol. 260, No. 11 Issue of Jun. 10, pp. 7142-7149 (1985).
Steinert et al., J. of Investigative Dermatology, vol. 100, p. 500 (1993).
Johnson et al., Proc. Natl. Acad. Sci. USA, vol. 82, pp. 1896-1900, Apr. 1985.
DiGiovanna John J.
Goldman Robert D.
Steinert Peter M.
Schain Howard E.
United States of America
Use of synthetic peptides to disrupt the cytoskeleton does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with Use of synthetic peptides to disrupt the cytoskeleton, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of synthetic peptides to disrupt the cytoskeleton will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-222898